Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pelican BioThermal, the global name in temperature-controlled packaging solutions, is unifying its brand across the globe. The company will now be known worldwide as Peli BioThermal. After growing its BioPharma Division through acquisitions from 2012...
read more
Recro Pharma Inc, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced the signing of a development and ...
read more
DFE Pharma, a global leader in pharmaceutical excipient solutions, is excited to announce the launch of a new addition to its broad excipient portfolio, Pharmacel® sMCC 90, a silicified microcrystalline cellulose (MCC).
read more
Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small ...
read more
H.E.L Group (H.E.L), a developer and manufacturer of laboratory tools for process optimization, safety, and scale-up, announced that it has expanded its operations in North America, with the establishment of a West Coast hub in California, and a ...
read more
MediPharm Labs Corp., a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, has received a Drug Establishment Licence (the “DEL”) issued by Health Canada in accordance with the ...
read more
uMotif, experts in patient-centered clinical solutions, announced its collaboration with Xperiome, a global health technology company specializing in rare diseases. The partnership will bring value to both life science companies conducting clinical ...
read more
Curia, formerly AMRI, agreed to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing organization with facilities in California, Massachusetts, and Texas. LakePharma uses technology ...
read more
Blue Water Vaccines announced a novel virus-like particle (VLP) vaccine platform from Cincinnati Children's Hospital Medical Center (Cincinnati Children's). The platform utilizes nanoparticle delivery technology that has the potential for broad ...
read more
SP Scientific Products (SP) announces that to stay ahead of the ever-increasing global demand for its state-of-the-art fill-finish and lyophilization (freeze dryer) equipment, it has more than doubled its worldwide manufacturing capacity. Central to ...
read more
Inotiv, a research organization specializing in nonclinical and analytical drug discovery and development services, acquired genetic toxicology assets from MilliporeSigma’s BioReliance® portfolio, including standard operating procedures, stock ...
read more
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, agreed to acquire Integrity Bio Inc, a privately held formulation and fill-finish organization headquartered in Camarillo, California.
read more
Albany Molecular Research, a contract research development and manufacturing organization, announced that it is changing its name to Curia, effective July 12, 2021. The new name reinforces the company’s strategic positioning as an end-to-end global ...
read more
SRI International (SRI) announced a drug discovery research collaboration with Sanofi. By leveraging SRI’s SynFini™ platform, an artificial intelligence (AI)-guided, automated synthetic-chemistry system, the collaboration will discover and develop ...
read more
The acquisition of Pharmatech supports USPs commitment to strengthen the supply chain of quality medicines, builds on our longstanding work with regulators and manufacturers globally to solve some of the most critical and challenging problems in the ...
read more